Music Intervention for Muscular Dystrophy
Trial Summary
No, you will not have to stop taking your current medications. Participants are required to stay on stable medication from the day of screening to the end of the study.
A study on a 15-week recreational dance and singing program for people with neuromuscular conditions found no evidence of safety concerns, suggesting that such activities can be safe and meaningful.
12345Dalcroze music education is unique because it combines music and movement to improve physical, cognitive, and social abilities, which is different from traditional treatments that may focus solely on physical therapy or medication. This approach has shown benefits in improving balance, mobility, and social interaction, making it a novel option for enhancing quality of life in individuals with muscular dystrophy.
678910Eligibility Criteria
This trial is for children with congenital Myotonic Dystrophy Type 1 (DM1) who have brain and heart symptoms. They must be able to attend weekly music sessions for 10 weeks, provide biological samples, and use wearable devices for monitoring. Parents should also participate in questionnaires and focus groups.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend 45-minute-long music sessions once weekly for 10 weeks and provide biological samples
Follow-up
Participants are monitored for changes in physical and cognitive assessments, and qualitative feedback is collected
Extension
Participants may continue to use wearable devices for extended monitoring of brain-heart biomarkers